The concept reflects a measure of the influence a journal holds in the field of bridging basic neuroscience research with clinical applications and outcomes related to degenerative neurological disorders. It quantifies the frequency with which a journal’s articles are cited by other researchers, thus providing an indication of the journal’s relative importance within the broader scientific community focused on neurodegeneration and its treatment. As an example, a high value suggests that the journal’s publications are frequently referenced, indicating its significant contribution to the advancement of knowledge in the translation of research findings into practical therapies.
This metric is crucial because it provides a standardized method for assessing the relevance and impact of research specifically aimed at translating basic discoveries into clinical benefits for individuals affected by neurodegenerative diseases. It helps researchers identify leading journals in the field, allowing them to stay abreast of the most influential advancements. Furthermore, it assists funding agencies in evaluating the impact of research grants and identifying promising areas for future investment. The development of this measure reflects a growing emphasis on accelerating the movement of laboratory findings towards real-world applications that can improve the lives of patients suffering from debilitating neurological conditions.
